2-Aminopyridine-3,5-dicarbonitrile compounds were previously identified as mimetics of dominant-negative prion protein mutants and inhibit prion replication in cultured cells. Here, we report findings from a comprehensive structure-activity relationship study of the 6-aminopyridine-3,5-dicarbonitrile scaffold. We identify compounds with significantly improved bioactivity (approximately 40-fold) against replication of the infectious prion isoform (PrPSc) and suitable pharmacokinetic profiles to warrant evaluation in animal models of prion disease.
Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics / May, Bc; Zorn, Ja; Witkop, J; Sherrill, J; Wallace, Ac; Legname, Giuseppe; Prusiner, Sb; Cohen, Fe. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 50:1(2007), pp. 65-73.
Titolo: | Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics |
Autori: | May, Bc; Zorn, Ja; Witkop, J; Sherrill, J; Wallace, Ac; Legname, Giuseppe; Prusiner, Sb; Cohen, Fe |
Rivista: | |
Data di pubblicazione: | 2007 |
Volume: | 50 |
Fascicolo: | 1 |
Pagina iniziale: | 65 |
Pagina finale: | 73 |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1021/jm061045z |
Appare nelle tipologie: | 1.1 Journal article |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
May_JMedChem_2007.pdf | Versione Editoriale (PDF) | Non specificato | Administrator Richiedi una copia |